Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesCardiologyPremera Bluecross Angiography Prior Auth | OpenPay…
    Ask Trek AI about this page
    ModifiedPremera BluecrossPolicy 2.02.507

    Coronary Angiography for Known or Suspected Coronary Artery Disease in Adults

    Customize your policy alerts

    Sign up for Premera Bluecross Policy 2.02.507 alerts

    Get alerted when Policy 2.02.507 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical-necessity review for elective coronary angiography and review of the medically necessary site of service. It applies to adults aged 19 and older and informs providers when coronary angiography may be covered for known or suspected coronary artery disease and related high-risk cardiac conditions.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerPremera Bluecross
    PolicyCoronary Angiography for Known or Suspected Coronary Artery Disease in Adults
    Policy CodePolicy 2.02.507
    Change TypeModified
    Effective DateSep 1, 2026
    Last ReviewAug 11, 2026
    Next Review DateN/A
    Key ActionWhen symptoms or functional capacity change despite guideline-directed medical therapy, use stress imaging or other noninvasive testing for ischemia and risk stratification before considering revascularization when clinically appropriate.
    SourceLink
    POLICY UPDATE CHANGES

    The policy added an optimal medical treatment requirement for stable angina for each Canadian Cardiovascular Society class.

    The policy updated unstable-disease criteria involving ventricular enlargement or a transient ischemic dilation ratio greater than 1.2.

    The policy expanded its practice-guideline and position-statement references to include newer chronic coronary disease, acute coronary syndrome, and multimodality appropriate-use guidance.

    19+Minimum age
    7Indications without medical review
    2+Anti-anginal medication classes for optimal treatment
    12 moRecurrent ischemia window after CABG
    ≥50%Unprotected left-main stenosis threshold

    Medical Necessity and Site-of-Service Criteria

    Conditions that do not require medical review

    Coronary angiography may be considered medically necessary for the following conditions that do not require medical review.

    Conditions not requiring medical review: The individual has congenital heart disease; heart failure; hypertrophic cardiomyopathy; Kawasaki disease; pulmonary artery extrinsic compression of the left main coronary artery; valvular disease; or is post cardiac transplant and has not undergone coronary angiography in the preceding six months.

    The source also lists individuals age 19 or younger; however, the policy states that it applies only to adults aged 19 and older.

    Known or suspected coronary artery disease

    Coronary angiography for known or suspected coronary artery disease may be considered medically necessary when criteria for any one of the following indication groups are met.

    Qualifying CAD-related indications

    • Angina

      • Unstable angina or NSTEMI risk factors: Elevated troponin; ischemia-related heart failure; persistent hemodynamic or electrical instability; LVEF less than 40%; prior PCI in the past 6 months or prior CABG in the past 12 months; suspected or confirmed new ST-segment depression; sustained ventricular arrhythmia; or recurrent angina or ischemia at rest or low activity for greater than 20 minutes despite OMT.

        Any one listed risk factor supports the unstable-angina/NSTEMI indication.

    • High risk for CAD based on non-invasive findings: High risk for CAD based on any listed non-invasive finding.

      Qualifying findings include an echocardiographic wall-motion abnormality involving greater than 2 segments; Duke Treadmill Score less than or equal to -11; resting LVEF 35% or less; stress ECG with ST-segment elevation, ventricular arrhythmia, or at least 2 mm ST-segment depression; a stress-induced large perfusion defect, particularly anterior, or multiple moderate-size perfusion defects; stress-induced LV dysfunction with exercise LVEF less than 35%; or significant stenosis of at least 50% in an unprotected left main coronary artery on recent CCTA.

    • High risk for CAD on myocardial perfusion imaging: A large fixed perfusion defect with LV dilatation or increased lung uptake of radioisotope; a stress-induced moderate perfusion defect with LV dilatation or increased lung uptake; or LV enlargement or transient ischemic dilation.TID ratio greater than 1.2

      Any one listed myocardial-perfusion finding supports medical necessity.

    • After acute myocardial infarction: Risk stratification after acute MI when clinically significant heart failure occurred during the hospital course; ischemia was provoked by minimal exercise on non-invasive testing; or LVEF is 45% or less and the individual is unable to undergo non-invasive testing.LVEF 45% or less when unable to undergo non-invasive testing

      Any one listed post-MI condition supports medical necessity.

    • Other high-risk factors: Ischemia recurring, verified clinically or by non-invasive testing, within 12 months of CABG; suspected acute pericarditis when signs, symptoms, troponin levels, and ST-elevation pattern cannot definitively rule out acute infarction; survival of sudden cardiac arrest or sustained ventricular tachycardia; need for cardiac risk assessment before high-risk non-cardiac surgery when disability, illness, or physical challenge precludes non-invasive testing; suspected stent thrombosis following PCI; or reevaluation of a specific area or structure with the same imaging modality because of changed clinical status, need for re-imaging before or after an invasive procedure, or need for interval reassessment that may affect the treatment plan.

    Inpatient site of service

    An inpatient hospital or medical center is a medically necessary site of service for certain elective surgical procedures when the individual has a clinical condition that increases the risk of complications.

    Inpatient site-of-service risk criteria: An inpatient hospital or medical center is medically necessary when any listed elevated-risk condition is present: ASA classification III or higher; personal history of anesthesia complication; alcohol dependence or history of cocaine use; prolonged surgery greater than 3 hours; uncompensated chronic heart failure NYHA class III or IV; recent MI less than 3 months; poorly controlled resistant hypertension; recent cerebrovascular accident less than 3 months; increased risk for cardiac ischemia; advanced liver disease with MELD score greater than 8; COPD with FEV1 less than 50%; poorly controlled asthma with FEV1 less than 80% despite treatment; moderate to severe OSA; end-stage renal disease on dialysis; morbid obesity with BMI greater than or equal to 50; pregnancy; bleeding disorder requiring replacement factor, blood products, or special infusion product; or anticipated need for transfusion(s).

    Resistant hypertension is defined as requiring 3 or more drugs to control blood pressure. Moderate OSA is AHI greater than or equal to 15 and less than or equal to 30; severe OSA is AHI greater than or equal to 30. DDAVP does not meet the bleeding-disorder criterion.

    Covered or clinically supported indications

    Coronary angiography is supported when one or more of the following clinical circumstances apply and the findings will inform risk assessment or therapeutic decision-making.

    Supported indications

    • Sudden cardiac death or life-threatening ventricular arrhythmia: Stable ischemic heart disease with prior sudden cardiac death or potentially life-threatening ventricular arrhythmia.
    • Heart failure symptoms or newly diagnosed HFrEF: Stable ischemic heart disease with symptoms and signs of heart failure, or newly diagnosed heart failure with reduced ejection fraction without prior coronary artery disease evaluation.
    • High-risk noninvasive evaluation: Clinical characteristics and noninvasive testing indicate a high likelihood of severe ischemic heart disease, and benefits are judged to exceed risk.
    • Depressed LV function with ischemia:

    Not recommended or not medically necessary

    Coronary angiography is not recommended or is not medically necessary when one or more of the following conditions apply.

    Not recommended or not medically necessary circumstances

    • No revascularization intent or candidacy: The individual elects not to undergo revascularization or is not a candidate because of comorbidities or individual preferences.
    • Preserved function and low-risk testing: Stable ischemic heart disease with preserved LV function and low-risk noninvasive testing.EF >50%
    • Low clinical risk without noninvasive testing: The individual is at low risk according to clinical criteria and has not undergone noninvasive risk testing.

    Coronary angiography for known or suspected coronary artery disease is not medically necessary when none of the policy’s listed medical-necessity criteria are present. Submitted records should identify the applicable diagnosis or condition, severity, prior imaging or testing, prior procedures, and other relevant high-risk factors.

    The policy’s site-of-service medical-necessity criteria do not apply to Indian Health Services facilities. For procedures performed at an IHS facility, apply the medical-necessity criteria for the coronary angiography procedure itself.

    Do not perform coronary angiography solely for risk assessment when the individual elects not to undergo revascularization or is not a revascularization candidate because of comorbidities or individual preferences.

    Do not perform coronary angiography to assess risk in an asymptomatic individual who has no evidence of ischemia on noninvasive testing.

    An occupation involving the safety of others, age, or a sedentary lifestyle alone does not establish sufficient risk to proceed directly to coronary angiography. These factors are not medically necessary justification without another qualifying diagnosis, risk factor, or abnormal noninvasive finding listed in the policy.

    For an elective procedure, an inpatient hospital or medical center is not medically necessary when the individual does not meet the policy’s inpatient site-of-service risk criteria. The criteria include specified elevated-risk conditions such as ASA classification III or higher, recent myocardial infarction, significant cardiopulmonary disease, end-stage renal disease on dialysis, pregnancy, anticipated transfusion, or morbid obesity with BMI ≥50.

    Coronary angiography for known or suspected coronary artery disease is not medically necessary when the request does not meet any of the policy’s listed clinical indications. Documentation must support a qualifying diagnosis or condition and include the relevant examination findings, prior testing, procedures, and high-risk factors.

    Direct invasive angiography is rarely appropriate when symptoms are less likely to be anginal and have a clear noncardiac explanation. Occupation, age, or sedentary lifestyle does not provide sufficient clinical risk justification by itself; abnormal noninvasive testing and other qualifying clinical factors should guide the decision.

    Codes, Thresholds, and Clinical Reference Values

    Covered CPT CodesCPTCovered
    93454Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation.
    93455Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography.
    93456Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization.
    Covered HCPCS CodesHCPCSCovered
    C7516Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, and interpretation.
    C7517Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, nonselective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography.
    C7518Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) including intraprocedural injection(s) for bypass graft angiography.
    C7519Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) including intraprocedural injection(s) for bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement during coronary angiography including pharmacologically induced stress.
    C7520Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) including intraprocedural injection(s) for bypass graft angiography with iliac and/or femoral artery angiography.
    C7521Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using IVUS or OCT.
    C7522Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right heart catheterization, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement during coronary angiography including pharmacologically induced stress.
    C7523Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using IVUS or OCT.
    C7524Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed.
    C7525Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with coronary flow reserve measurement during coronary angiography including pharmacologically induced stress.
    1–10 of 14
    1/2
    HCPCS CodesHCPCS
    C7569Branch with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention, including imaging supervision, interpretation and report (new code effective 01/01/26).
    C7570Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with intraprocedural coronary fractional flow reserve (FFR) with 3D functional mapping of color-coded FFR values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(ies) intervention; list separately in addition to the code for the primary procedure (new code effective 01/01/26).
    Threshold
    ConditionUnprotected left-main coronary stenosis
    ThresholdAt least 50%
    AssessmentOn recent coronary CT angiography (CCTA)
    Threshold
    Risk categoryHigh-risk Duke Treadmill Score
    ThresholdScore of -11 or lower
    Use

    Documentation, Review, and Denial Risks

    Prior Authorization

    Medical-Necessity and Site-of-Service Review

    Premera will review coronary angiography for medical necessity and will also review the medical necessity of the elective procedure's site of service. Submit the procedure and requested setting for review, including the clinical facts supporting both.

    • Reviewed sites include off-campus outpatient hospital/medical center, on-campus outpatient hospital/medical center, and ambulatory surgical center.
    • An inpatient hospital/medical center is medically necessary only when an increased-risk clinical condition supports that setting.
    Documentation Required

    Noninvasive Assessment Before Intervention

    When symptoms or functional capacity change despite guideline-directed medical therapy, document the reassessment pathway before or alongside intervention. Noninvasive testing is recommended to detect and quantify ischemia, estimate risk, and guide therapeutic decisions.

    Clinical Background

    Coronary angiography uses injected contrast dye and fluoroscopic X-rays to visualize blood flow through the coronary arteries and identify narrowing or blockage. The findings help determine whether treatment is needed and what type of treatment may be appropriate. This policy addresses when coronary angiography may be medically necessary for adults with known or suspected coronary artery disease and selected related cardiac conditions.

    Policy and Clinical Definitions

    Definition
    TestCoronary angiogram
    MethodUses a special dye and fluoroscopy
    PurposeShows blood flow through the coronary arteries and identifies narrowed or blocked arteries
    Definition
    Medication countTwo or more anti-anginal medications
    Medication classesDifferent therapeutic classes
    Required classA beta-blocker or calcium channel blocker, or both, unless contraindicated
    Policy Summary
    PayerPremera Bluecross
    PolicyCoronary Angiography for Known or Suspected Coronary Artery Disease in Adults
    Policy CodePolicy 2.02.507
    Change TypeModified
    Effective DateSep 1, 2026
    Last ReviewAug 11, 2026
    Next Review DateN/A
    Key ActionWhen symptoms or functional capacity change despite guideline-directed medical therapy, use stress imaging or other noninvasive testing for ischemia and risk stratification before considering revascularization when clinically appropriate.
    SourceLink
    On This Page
    Medical Necessity and Site-of-Service CriteriaCodes, Thresholds, and Clinical Reference ValuesDocumentation, Review, and Denial RisksClinical BackgroundPolicy and Clinical Definitions
    Stable ischemic heart disease with depressed LV function and moderate-risk noninvasive criteria with demonstrable ischemia.
    EF <50%

    Class IIa recommendation.

  1. Inconclusive or unsuitable noninvasive testing: Noninvasive testing provides inconclusive prognostic information, or is contraindicated or inadequate.
  2. Persistent angina with intermediate risk: Unsatisfactory quality of life due to angina, preserved LV function, and intermediate-risk noninvasive criteria.EF >50%
  3. Symptoms despite medical therapy: Chronic coronary disease with a change in symptoms or functional capacity that persists despite guideline-directed medical therapy, when angiography will guide therapeutic decision-making and improve anginal symptoms.

    Class I recommendation.

  4. High-risk acute coronary syndrome: Acute coronary syndrome with high-risk clinical features or objective evidence of ischemia where angiography will guide revascularization or other treatment decisions.

    Risk features may include elevated cardiac biomarkers, hemodynamic instability, recurrent ischemia, or significant arrhythmias.

  5. Appropriate-use clinical or imaging findings: Symptomatic likely anginal symptoms with age 50 years or older and/or at least two cardiovascular risk factors; moderate-to-severe ischemia on stress imaging; severe coronary stenosis on CCTA; or newly diagnosed HFrEF without prior coronary evaluation.Age 50 years or older and/or 2 or more risk factors; CAD-RADS 4-5 for severe stenosis
  6. Unable to complete noninvasive testing: The individual cannot undergo exercise treadmill testing or stress imaging because of intolerance to pharmacologic stress or technical limitations such as obesity or severe pulmonary disease, or has been resuscitated from cardiac arrest or has a premonitory malignant ventricular rhythm.
  7. "operator":"any","label":"Stable ischemic heart disease symptom indication","text":"Presumed stable ischemic heart disease with unacceptable ischemic symptoms despite guideline-directed medical treatment, provided the individual is amenable to and a candidate for coronary revascularization.","note":"Class I recommendation."}
    Asymptomatic without ischemia:
    The individual is asymptomatic and has no evidence of ischemia on noninvasive testing.
  8. Noncardiac explanation for symptoms: Symptoms are less likely to be anginal and have a clear noncardiac explanation.

    Invasive angiography is rarely appropriate.

  9. Occupation or lifestyle alone: Occupation involving safety of others, age, or sedentary lifestyle is used alone, without another qualifying diagnosis or risk factor, to justify direct angiography.

    Considered not medically necessary.

  10. "operator":"all","label":"No qualifying evidence","text":"The request is based only on low risk, absence of ischemia, noncardiac symptoms, or occupational or lifestyle factors without a documented indication elsewhere in the policy."
    Indicates high risk for coronary artery disease based on noninvasive findings
    Threshold
    MeasureResting left ventricular ejection fraction (LVEF)
    Threshold35% or less
    UseSupports a high-risk noninvasive finding
    Threshold
    FindingStress-induced ST-segment depression
    ThresholdAt least 2 mm
    TestStress electrocardiogram
    Threshold
    ArrhythmiaVentricular tachycardia or sustained ventricular fibrillation
    DurationAt least 30 seconds
    Clinical settingUnstable angina or NSTEMI with high or intermediate risk for adverse outcome
    Threshold
    SymptomRecurrent angina or ischemia
    Activity levelAt rest or low activity
    ThresholdMore than 20 minutes despite optimal medical treatment (OMT)
    Threshold
    MeasureTransient ischemic dilation (TID) ratio
    ThresholdGreater than 1.2
    FindingLeft ventricular enlargement or transient ischemic dilation on myocardial perfusion imaging
    Threshold
    ConditionProlonged surgery
    ThresholdGreater than 3 hours
    Review areaInpatient site-of-service risk criterion
    Threshold
    ConditionMorbid obesity
    ThresholdBMI of at least 50
    Review areaInpatient site-of-service risk criterion
    Duke Treadmill Score
    Risk categoryLow risk
    Score thresholdAt least 5
    Five-year mortality1%
    Duke Treadmill Score
    Risk categoryIntermediate risk
    Score rangeBetween +5 and -11
    Five-year mortality10%
    Duke Treadmill Score
    Risk categoryHigh risk
    Score threshold-11 or lower
    Five-year mortality35%
    LV Function
    MeasureLeft ventricular function
    ThresholdEF below 50%
    Clinical settingStable ischemic heart disease with moderate-risk noninvasive criteria and demonstrable ischemia
    LV Function
    MeasureLeft ventricular function
    ThresholdEF above 50%
    Clinical useUsed with intermediate- or low-risk noninvasive testing
    CCTA Assessment
    TestCoronary CT angiography (CCTA)
    Stent size3 mm or smaller
    PurposeEvaluate bypass graft or stent patency after previous coronary revascularization
    Clinical Risk Profile
    Age50 years or older
    Risk factorsTwo or more cardiovascular risk factors
    Applicable profileSymptomatic individuals with likely anginal symptoms meeting the age and/or risk-factor profile
    CCTA Finding
    TestCoronary CT angiography (CCTA)
    Severity classificationCAD-RADS 4-5
    FindingSevere coronary stenosis
    • Use PET/SPECT myocardial perfusion imaging, cardiac magnetic resonance imaging, or stress echocardiography to evaluate persistent symptoms and ischemia.
    • After prior revascularization, coronary CT angiography may be reasonable to evaluate bypass-graft or stent patency when applicable, including stents 3 mm or smaller.
    Documentation Required

    Required Medical Records

    Submit medical records that establish the applicable medical-necessity criteria for coronary angiography. Incomplete records may prevent confirmation of coverage.

    • Diagnosis or condition.
    • History and physical examination documenting severity.
    • Results and reports from prior imaging or testing.
    • Prior procedures.
    • Other high-risk factors.
    Documentation Required

    Clinical Rationale and Test Results

    Support the request with the patient's clinical presentation, disease status, symptoms, left-ventricular function, noninvasive test results, and overall risk category. The record should explain why the expected benefit of angiography exceeds its risks and how the findings will affect treatment.

    • High likelihood of severe ischemic heart disease with benefits expected to exceed risk supports angiography.
    • Depressed LV function (EF <50%) with moderate-risk noninvasive testing and demonstrable ischemia may support further risk assessment.
    • Inconclusive, contraindicated, or inadequate noninvasive testing may support angiography.
    • Preserved LV function (EF >50%) with intermediate-risk testing and unsatisfactory angina-related quality of life may support angiography.
    Documentation Required

    Persistent Symptoms Despite Medical Therapy

    For chronic coronary disease, document a change in symptoms or functional capacity that persists despite guideline-directed medical therapy and explain how angiography will guide therapeutic decision-making and improve anginal symptoms.

    • Document the therapy provided, the patient's response, and the current symptom or functional decline.
    • Link the requested angiography to a treatment decision, such as revascularization or another change in management.
    Denial Risk

    Acute Coronary Syndrome Risk

    For acute coronary syndromes, document the high-risk presentation and objective evidence supporting an invasive strategy. Explain how angiography will guide PCI, CABG, or optimal medical therapy.

    • High-risk clinical features or objective evidence of ischemia.
    • Risk-stratification findings such as elevated cardiac biomarkers, hemodynamic instability, recurrent ischemia, or significant arrhythmias.
    • Clinical presentation, risk assessment, comorbidities, and patient-specific factors supporting invasive management.
    Denial Risk

    No Qualifying Medical-Necessity Indication

    Coronary angiography is considered not medically necessary when the applicable policy criteria are absent. Ensure the submitted documentation identifies the qualifying condition, symptoms, testing, risk, or treatment-planning need.

    • A request without documented medical-necessity criteria is at risk for denial.
    Denial Risk

    Inpatient Site Criteria Not Met

    An elective inpatient hospital or medical-center setting is not medically necessary when the policy's inpatient site criteria are not met. Use the least intensive medically appropriate setting unless the record supports increased risk for complications.

    • Support inpatient care with applicable anesthesia, cardiovascular, pulmonary, renal, or other risk factors.
    • Examples include ASA III or higher, uncompensated NYHA III-IV heart failure, recent MI or stroke, ESRD on dialysis, BMI at least 50, pregnancy, qualifying bleeding disorder, or anticipated transfusion.
    • DDAVP alone does not meet the policy's bleeding-disorder criterion.

    Unsupported block type: denial_risk set??

    Unsupported block type: denial_risk

    Denial Risk

    Low-Risk Evaluation

    Risk-assessment angiography is not recommended when LV function is preserved and noninvasive testing indicates low risk. Submit the LV ejection fraction and the noninvasive risk result.

    • Preserved LV function means EF >50%.
    • Low-risk noninvasive testing does not support angiography for further risk assessment.
    Denial Risk

    Asymptomatic Without Ischemia

    Risk-assessment angiography is not recommended in an asymptomatic individual with no evidence of ischemia on noninvasive testing. Document symptoms and ischemic findings when present.

    • An absence of symptoms and ischemia creates a denial risk for this indication.
    Denial Risk

    Insufficient Clinical Risk

    Angiography is rarely appropriate when symptoms are less likely to be anginal and there is a clear noncardiac explanation. Age or sedentary lifestyle alone does not establish sufficient risk for proceeding directly to angiography.

    • Base the request on symptoms, cardiovascular risk factors, prior testing, and overall clinical risk assessment.
    • A safety-sensitive occupation combined only with sedentary lifestyle does not establish medical necessity.
    Definition
    DefinitionThe location where the surgical procedure is performed
    Outpatient examplesOff-campus outpatient hospital or medical center; on-campus outpatient hospital or medical center; ambulatory surgical center
    Inpatient exampleInpatient hospital or medical center
    Definition
    Full nameCanadian Cardiovascular Society classification of angina severity
    Class IOrdinary physical activity does not cause angina
    Class IVInability to carry on any physical activity without discomfort; anginal syndrome may be present at rest
    Definition
    ClassificationAmerican Society of Anesthesiologists (ASA) physical status classification
    Relevant levelASA class III or higher
    Policy useAn anesthesia-risk condition supporting inpatient site of service
    Definition
    ProcedureSurgical procedure
    PurposeRestores blood flow to the heart by bypassing blocked or narrowed coronary arteries
    MaterialsUses arterial or venous grafts obtained from another part of the body
    Definition
    TestNoninvasive imaging study
    MethodUses computed tomography and intravenous contrast material
    PurposeVisualizes the coronary arteries and evaluates coronary artery stenosis or obstruction
    Definition
    MeasurePercentage of blood ejected from the left ventricle during each cardiac contraction
    Clinical useAssesses left ventricular systolic function
    AbbreviationLVEF
    Definition
    ProcedureMinimally invasive catheter-based procedure
    MethodUses a catheter and contrast dye to visualize the coronary arteries
    PurposeDetects blockages or narrowing
    Definition
    ConditionAcute myocardial infarction
    BiomarkersElevated cardiac biomarkers
    ElectrocardiographyWithout persistent ST-segment elevation
    Definition
    ProcedureCatheter-based coronary revascularization procedure
    PurposeOpens narrowed or blocked coronary arteries
    MethodsTypically balloon angioplasty, stent placement, or both
    Definition
    DiseaseSignificant narrowing or obstruction of the left main coronary artery
    Bypass statusNot bypassed by a CABG
    Anatomic clarificationNo prior surgical bypass to the left anterior descending or circumflex arteries
    Definition
    Full nameCanadian Cardiovascular Society Functional Classification of Angina
    PurposeDescribes angina severity and the degree to which symptoms limit physical activity
    ClassesClass I, II, III, and IV
    Definition
    FormulaDTS = exercise time in minutes − (5 × ST deviation in millimeters) − (4 × angina index)
    Low riskScore of at least 5
    High riskScore of -11 or less
    Definition
    ClassificationHeart-failure functional classification
    Class INo symptoms and no limitation in ordinary physical activity
    Class IVSevere limitations with symptoms even while at rest
    Place of Service
    FacilityOff-campus outpatient hospital department
    ServicesDiagnostic, therapeutic, and rehabilitation services for persons who do not require hospitalization or institutionalization
    Place-of-service code19
    Place of Service
    FacilityInpatient hospital
    ServicesDiagnostic, therapeutic, and rehabilitation services for admitted patients
    Place-of-service code21
    Place of Service
    FacilityOn-campus outpatient hospital department
    ServicesDiagnostic, therapeutic, and rehabilitation services for persons who do not require hospitalization or institutionalization
    Place-of-service code22
    Place of Service
    FacilityFreestanding ambulatory surgical facility
    ServicesSurgical and diagnostic services provided on an ambulatory basis
    Place-of-service code24